Internal Medicine, Rheumatology · Great Neck, NY
NPI
1508937905
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
865 Northern Blvd, Suite 302
Great Neck, NY, 11021
Phone (516) 708-2555
Groups this clinician bills Medicare through
Medicare paid, 2024
$835K
65,793 services
Medicare patients, 2024
298
Average age 73
Drug cost, 2024
$1.6M
1,622 prescriptions
Company payments, 2024
$13.24
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria-Louise Barilla-Labarca was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 457 times for 176 patients. In total Maria-Louise Barilla-Labarca billed 65,793 services in 53 codes, and Medicare paid $835K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 457 | 176 | $14.25 | $6,512 |
| 99214 Office E&M - Established | Office | 361 | 165 | $109.23 | $39K |
| 96365 Intravenous Infusion, Hydration | Office | 186 | 34 | $59.89 | $11K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 140 | 28 | $4.31 | $604 |
| 99215 Office E&M - Established | Office | 121 | 80 | $153.99 | $19K |
| 96374 Injection Administration | Office | 96 | 42 | $33.15 | $3,183 |
| 36415 Venipuncture Blood Collection | Office | 88 | 46 | $8.55 | $753 |
| 99213 Office E&M - Established | Office | 72 | 53 | $79.13 | $5,697 |
| 96413 Chemotherapy Administration | Office | 71 | 17 | $122.85 | $8,723 |
| 99205 Office E&M - New | Office | 56 | 56 | $187.49 | $10K |
| 96415 Chemotherapy Administration | Office | 54 | 12 | $25.32 | $1,367 |
| 20610 Joint Injection | Office | 19 | 12 | $73.95 | $1,405 |
| 99442 Telephone Services | Office | 17 | 14 | $72.15 | $1,226 |
| 99443 Telephone Services | Office | 16 | 12 | $118.82 | $1,901 |
By year: 2022 $1.0M for 35,546 services; 2023 $698K for 51,488 services; 2024 $835K for 65,793 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 88 | 46 | $8.55 | $753 |
Medicare prescription drug claims, 2024
In 2024, the drug Maria-Louise Barilla-Labarca prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 278 prescriptions and refills. In total Maria-Louise Barilla-Labarca wrote 1,622 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 278 | 569 | 63 | $9,810 |
| Prednisone Generic | 190 | 239 | 44 | $840 |
| Allopurinol Generic | 162 | 328 | 31 | $952 |
| Methotrexate Methotrexate Sodium | 140 | 290 | 37 | $3,316 |
| Enbrel Sureclick Etanercept | 56 | 60 | Under 11 | $433K |
| Colchicine Generic | 54 | 80 | 12 | $1,720 |
| Humira(Cf) Pen Adalimumab | 49 | 69 | Under 11 | $452K |
| Methylprednisolone Generic | 46 | 49 | 37 | $391 |
| Otezla Apremilast | 45 | 47 | Under 11 | $226K |
| Meloxicam Generic | 43 | 79 | 22 | $288 |
| Duloxetine Hcl Generic | 39 | 76 | 11 | $1,261 |
| Tramadol Hcl Generic | 37 | 37 | Under 11 | $497 |
| Cyclobenzaprine Hcl Generic | 31 | 33 | 14 | $136 |
| Mycophenolate Mofetil Generic | 29 | 59 | Under 11 | $3,389 |
| Otrexup Methotrexate/Pf | 27 | 31 | Under 11 | $22K |
Brand drugs: - claims; generic drugs: 1,354 claims; opioid claims: 42.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Maria-Louise Barilla-Labarca $13.24 ($13.24 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $13.24.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $13.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.